ATE489420T1 - Biokompatibles vernetztes gel - Google Patents

Biokompatibles vernetztes gel

Info

Publication number
ATE489420T1
ATE489420T1 AT05717516T AT05717516T ATE489420T1 AT E489420 T1 ATE489420 T1 AT E489420T1 AT 05717516 T AT05717516 T AT 05717516T AT 05717516 T AT05717516 T AT 05717516T AT E489420 T1 ATE489420 T1 AT E489420T1
Authority
AT
Austria
Prior art keywords
crosslinking
solution
polymer
biocompatible
linked gel
Prior art date
Application number
AT05717516T
Other languages
English (en)
Inventor
Laurence Hermitte
Olivier Benoit
Original Assignee
Anteis Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anteis Sa filed Critical Anteis Sa
Application granted granted Critical
Publication of ATE489420T1 publication Critical patent/ATE489420T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/24—Crosslinking, e.g. vulcanising, of macromolecules
    • C08J3/245—Differential crosslinking of one polymer with one crosslinking type, e.g. surface crosslinking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075—Macromolecular gels

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT05717516T 2004-02-03 2005-01-31 Biokompatibles vernetztes gel ATE489420T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0400987A FR2865737B1 (fr) 2004-02-03 2004-02-03 Gel reticule biocompatible
PCT/FR2005/000197 WO2005085329A1 (fr) 2004-02-03 2005-01-31 Gel reticule biocompatible

Publications (1)

Publication Number Publication Date
ATE489420T1 true ATE489420T1 (de) 2010-12-15

Family

ID=34746373

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05717516T ATE489420T1 (de) 2004-02-03 2005-01-31 Biokompatibles vernetztes gel

Country Status (15)

Country Link
US (1) US8052990B2 (de)
EP (1) EP1711552B1 (de)
JP (1) JP5105274B2 (de)
KR (1) KR101044339B1 (de)
CN (1) CN100582146C (de)
AT (1) ATE489420T1 (de)
AU (1) AU2005219595B2 (de)
BR (1) BRPI0507294B8 (de)
CA (1) CA2554597C (de)
DE (1) DE602005024919D1 (de)
ES (1) ES2354699T3 (de)
FR (1) FR2865737B1 (de)
PL (1) PL1711552T3 (de)
RU (1) RU2377260C2 (de)
WO (1) WO2005085329A1 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1928918B1 (de) * 2005-09-27 2011-11-16 UNIVERSITE JOSEPH FOURIER - Grenoble 1 Mit einer polymerisierbaren gruppierung funktionalisiertes hydrogel und anwendungen davon als biosensoren oder bioreaktoren
WO2008034176A1 (en) * 2006-09-19 2008-03-27 Ultraceuticals R & D Pty Ltd Cross-linked polysaccharide gels
FR2909285A1 (fr) * 2006-12-01 2008-06-06 Anteis Sa "utilisation d'un gel anti-adhesif et anti fibrotique"
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
US20080287633A1 (en) * 2007-05-18 2008-11-20 Drumheller Paul D Hydrogel Materials
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
FR2918377B1 (fr) 2007-07-05 2010-10-08 Estelle Piron Gel co-reticule de polysaccharides
CA2658681A1 (en) * 2007-07-25 2009-02-19 S & V Technologies Ag Hyaluronic acid dispersion, production and use
PT2818184T (pt) 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
FR2924615B1 (fr) * 2007-12-07 2010-01-22 Vivacy Lab Hydrogel cohesif biodegradable.
FR2927255B1 (fr) * 2008-02-07 2011-08-12 Keysan Consulting Produits injectables biocompatibles a liberation de zinc et/ou de sel de saccharide sous forme de zinc et leurs utilisations.
JP5574083B2 (ja) * 2008-08-01 2014-08-20 アンタイス エス．エイ． 高い残留性及び容量を与える高い能力を有する注入可能なヒドロゲル
US8357795B2 (en) 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
CA2735173C (en) 2008-09-02 2017-01-10 Tautona Group Lp Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof
US8715266B2 (en) * 2008-09-12 2014-05-06 Aptissen Sa Glaucoma surgery
US9339514B2 (en) 2008-09-12 2016-05-17 Aptissen Sa Method for treating glaucoma
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
FR2945293B1 (fr) * 2009-05-11 2011-06-17 Teoxane Procede de preparation d'un gel reticule.
US20110172180A1 (en) 2010-01-13 2011-07-14 Allergan Industrie. Sas Heat stable hyaluronic acid compositions for dermatological use
US8586562B2 (en) 2010-03-12 2013-11-19 Allergan Industrie, Sas Fluid compositions for improving skin conditions
EP4062950A1 (de) 2010-03-22 2022-09-28 Allergan, Inc. Spritze mit dermalem füllstoff zur verstärkung von weichgewebe
FR2962040B3 (fr) * 2010-07-05 2012-08-10 Alain Villette Composition injectable comprenant un medicament injectable et un gel
US9005605B2 (en) 2010-08-19 2015-04-14 Allergan, Inc. Compositions and soft tissue replacement methods
US8889123B2 (en) 2010-08-19 2014-11-18 Allergan, Inc. Compositions and soft tissue replacement methods
US8883139B2 (en) 2010-08-19 2014-11-11 Allergan Inc. Compositions and soft tissue replacement methods
FR2968305B1 (fr) * 2010-12-06 2014-02-28 Teoxane Procede de preparation d'un gel reticule
FR2968996B1 (fr) 2010-12-17 2013-04-12 Anteis Sa Formulation aqueuse injectable sterile utilisee en ophtalmologie
WO2012143876A1 (en) 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint
RU2624239C2 (ru) 2011-06-03 2017-07-03 Аллерган, Инк. Составы кожного наполнителя, включая антиоксиданты
US9393263B2 (en) 2011-06-03 2016-07-19 Allergan, Inc. Dermal filler compositions including antioxidants
US20130096081A1 (en) 2011-06-03 2013-04-18 Allergan, Inc. Dermal filler compositions
US9408797B2 (en) 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment
US9662422B2 (en) 2011-09-06 2017-05-30 Allergan, Inc. Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation
US20130244943A1 (en) 2011-09-06 2013-09-19 Allergan, Inc. Hyaluronic acid-collagen matrices for dermal filling and volumizing applications
CN104105474B (zh) * 2011-09-14 2018-04-06 阿勒根公司 用于细纹治疗的真皮填充剂组合物
ITAN20110138A1 (it) 2011-10-12 2012-01-11 Regenyal Lab S R L Sintesi di un gel iniettabile multifasico a base di acido ialuronico monofasico libero e reticolato e di acido ialuronico bifasico associato con idrossiapatite con inibitore della ialuronidasi microincapsulato.
ITMI20120732A1 (it) 2012-05-03 2013-11-04 B S Srl Polisaccaridi reticolati a memoria di forma
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
IN2014DN10147A (de) * 2012-06-15 2015-08-21 Merz Pharma Gmbh & Co Kgaa
US20140315828A1 (en) 2013-04-22 2014-10-23 Allergan, Inc. Cross-linked silk-hyaluronic acid compositions
FR3006689A1 (fr) 2013-06-11 2014-12-12 Benedicte Vincente Tauzin Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu
HK1224315A1 (zh) * 2013-06-28 2017-08-18 Galderma S.A. 用於制备交联的透明质酸产物的方法
PL3049055T3 (pl) 2013-09-27 2019-05-31 Anteis Sa Sposób otrzymywania hydrożelu do wstrzykiwań na bazie kwasu hialuronowego zawierającego lidokainę dodaną w postaci proszku oraz środek alkaliczny, sterylizowanego ciepłem
AR099900A1 (es) 2014-04-01 2016-08-24 Merz Pharma Gmbh & Co Kgaa Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
WO2016051219A1 (en) 2014-09-30 2016-04-07 Allergan Industrie, Sas Stable hydrogel compositions including additives
FR3029928B1 (fr) 2014-12-15 2018-03-09 Teoxane Gel reticule
RU2715234C2 (ru) 2015-02-13 2020-02-26 Аллерган Эндюстри, Сас Имплантаты для моделирования, увеличения или коррекции частей лица, например подбородка
FR3037797B1 (fr) 2015-06-24 2018-08-17 Kylane Laboratoires Sa Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu
US20180177707A1 (en) 2015-06-30 2018-06-28 Merz Pharma Gmbh & Co. Kgaa Method of preparing a composition based on hyaluronic acid
ES2872551T3 (es) * 2015-06-30 2021-11-02 Merz Pharma Gmbh & Co Kgaa Método para la producción de ácido hialurónico reticulado
DE102015009271A1 (de) * 2015-07-19 2017-01-19 Tracey Lennemann Neue Verwendung von Hyaluronsäure
EP3334451B1 (de) * 2015-08-13 2020-10-28 Stoffel, Bertrand Zusammensetzung zum schutz von polysacchariden in gelenken
WO2017042301A1 (en) * 2015-09-09 2017-03-16 ETH Zürich Injectable macroporous hydrogels
EP3162813A1 (de) 2015-11-02 2017-05-03 Merz Pharma GmbH & Co. KGaA Verfahren zur abreicherung von epoxidsorten in vernetzten polysaccharidgelzusammensetzungen und dadurch erhaltene zusammensetzungen
ES2953928T5 (en) 2015-11-24 2025-11-27 Bmi Korea Co Ltd Composition for injection of hyaluronic acid, containing hyaluronic acid derivative and dna fraction, and use thereof
FR3044557B1 (fr) 2015-12-07 2017-12-01 Benedicte Vincente Gavard Molliard Tauzin Nouvelle composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
FR3047666A1 (fr) 2016-02-15 2017-08-18 Benedicte Vincente Gavard Molliard Tauzin Composition injectable; procede de preparation de ladite composition; utilisation de ladite composition
TWI727014B (zh) 2016-03-24 2021-05-11 德商梅茲製藥有限兩合公司 修飾透明質酸與其製造方法及其用途
CA2961868A1 (en) * 2016-04-08 2017-10-08 Johnson & Johnson Consumer Inc. Topical compositions containing cross-linked glycosaminoglycans
WO2018039496A1 (en) 2016-08-24 2018-03-01 Allergan, Inc. Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation
CN106397795B (zh) * 2016-08-31 2018-12-21 陕西佰傲再生医学有限公司 一种混合透明质酸凝胶及其制备方法
WO2018083195A1 (en) 2016-11-03 2018-05-11 Merz Pharma Gmbh & Co. Kgaa Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use
WO2018087272A1 (en) 2016-11-11 2018-05-17 Anteis S.A. Hyaluronic acid dermal fillers crosslinked with citric acid, method for making same and uses thereof
WO2018220283A1 (fr) 2017-05-29 2018-12-06 Kh Medtech Sarl Composition injectable sterile contenant de l'acide hyaluronique reticule et de l'articaine
JP7309716B2 (ja) 2017-12-22 2023-07-18 ガルデルマ ホールディング ソシエテ アノニム 注入可能なゲル製品
EP3743079A1 (de) * 2018-02-06 2020-12-02 Regen Lab SA Vernetzte hyaluronsäuren und kombinationen mit prp/bmc
US20190240335A1 (en) * 2018-02-07 2019-08-08 Promedon S.A. Biocompatible Hydrogel Compositions
WO2020030629A1 (en) 2018-08-07 2020-02-13 Merz Pharma Gmbh & Co. Kgaa Method for dynamic filtration of a cross-linked hydrogel
LU101045B1 (en) 2018-12-11 2020-06-11 Qventis GmbH Method for the manufacture and use of a bionic hydrogel composition for medical applications
EP4073148B1 (de) 2019-12-09 2025-02-12 Merz Pharma GmbH & Co. KGaA Verfahren zur herstellung einer zusammensetzung mit vernetztem hydrogel
EP4362993B1 (de) 2021-06-30 2026-04-22 Merz Pharma GmbH & Co. KGaA Mit polyethylenglykoldiglycidylether vernetzte, dermale hyaluronsäurefüllstoffe, verfahren zur herstellung davon und verwendungen davon
CN114470333B (zh) * 2022-03-09 2023-05-23 哈尔滨敷尔佳科技股份有限公司 交联重组胶原蛋白凝胶的制备方法
KR20250079371A (ko) 2023-11-27 2025-06-04 조은애 친환경 용매를 사용한 생분해성 고분자 마이크로그래뉼이 융합된 히알루론산 겔을 포함하는 조직 수복용 주사제 조성물 및 그 제조 방법

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5951789A (ja) * 1982-09-18 1984-03-26 Wako Pure Chem Ind Ltd 安定化酵素
US4716224A (en) * 1984-05-04 1987-12-29 Seikagaku Kogyo Co. Ltd. Crosslinked hyaluronic acid and its use
US6174999B1 (en) * 1987-09-18 2001-01-16 Genzyme Corporation Water insoluble derivatives of polyanionic polysaccharides
DE69329594T2 (de) * 1992-02-28 2001-05-31 Board Of Regents, The University Of Texas System Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung
HUT71776A (en) * 1994-03-21 1996-01-29 Ciba Geigy Ag Antibody conjugates with improved properties
EP0713707A1 (de) * 1994-11-23 1996-05-29 Collagen Corporation Injizierbare, in Situ vernetzbare Kollagenszusammensetzung für die Weichgewebevermehrung
FR2733426B1 (fr) * 1995-04-25 1997-07-18 Debacker Yves Dispositif medical pour le comblement des deformations du volume de la peau telles que rides et cicatrices par injection de 2 formes physico-chimiques differentes d'un polymere biologique
US5827937A (en) * 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
GB9902652D0 (en) * 1999-02-05 1999-03-31 Fermentech Med Ltd Process
RU2159111C1 (ru) * 1999-08-02 2000-11-20 Общество с ограниченной ответственностью "Новые медицинские технологии" Композиция для ухода за кожей лица
FR2811996B1 (fr) 2000-07-19 2003-08-08 Corneal Ind Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations
WO2002060971A1 (fr) * 2001-01-31 2002-08-08 Seikagaku Corporation Eponge polysaccharidique reticulee
JP4489437B2 (ja) * 2002-02-21 2010-06-23 エンセル，インコーポレイテッド 表面コーティングとしての固定化生物活性ヒドロゲルマトリックス
JP4958368B2 (ja) * 2002-02-28 2012-06-20 電気化学工業株式会社 架橋ヒアルロン酸

Also Published As

Publication number Publication date
DE602005024919D1 (de) 2011-01-05
EP1711552B1 (de) 2010-11-24
KR101044339B1 (ko) 2011-06-29
PL1711552T3 (pl) 2011-04-29
WO2005085329A1 (fr) 2005-09-15
AU2005219595B2 (en) 2010-07-29
CA2554597C (fr) 2012-04-24
CN1918219A (zh) 2007-02-21
JP5105274B2 (ja) 2012-12-26
ES2354699T3 (es) 2011-03-17
BRPI0507294A (pt) 2007-07-03
JP2007520612A (ja) 2007-07-26
US8052990B2 (en) 2011-11-08
RU2377260C2 (ru) 2009-12-27
BRPI0507294B1 (pt) 2019-02-19
FR2865737A1 (fr) 2005-08-05
EP1711552A1 (de) 2006-10-18
AU2005219595A1 (en) 2005-09-15
CN100582146C (zh) 2010-01-20
CA2554597A1 (fr) 2005-09-15
KR20070004611A (ko) 2007-01-09
FR2865737B1 (fr) 2006-03-31
US20070196426A1 (en) 2007-08-23
RU2006127591A (ru) 2008-02-10
BRPI0507294B8 (pt) 2021-07-27

Similar Documents

Publication Publication Date Title
DE602005024919D1 (de) Biokompatibles vernetztes gel
Zhao et al. Versatile hydrogel dressing with skin adaptiveness and mild photothermal antibacterial activity for methicillin‐resistant staphylococcus aureus‐infected dynamic wound healing
BR0212389A (pt) Produção de materiais biopolìmeros como pelìcula, fibra, espuma ou adesivo a partir de derivados solúveis de queratina s-sulfonada
DE502005002746D1 (de) Verwendung eines Haarbehandlungsmittel mit Gehalt an einer Polymerkombination
ATE468357T1 (de) Biologisch abbaubare, superabsorbente polymere hydrogele und verfahren zu deren herstellung
BRPI0413738A (pt) processo para a polimerização por pulverização de uma solução de monÈmero, e, polìmeros intumescìveis em água
WO2006056204A8 (en) Method of cross-linking hyaluronic acid with divinylsulfone
RU2011107878A (ru) Гели на основе гиалуроновой кислоты, включающие обезболивающие агенты
CN104623725A (zh) 生物粘合剂及其制备方法
DE60029231D1 (de) Schwefelhaltige polymere als emulsionsstabilisator mit verbessertem koagulatniveau
BR0015237B1 (pt) mÉtodos para a preparaÇço e para a fabricaÇço de um sistema de catalisador suportado, e processo para a polimerizaÇço de olefinas.
EA200400966A1 (ru) Новые лекарственные формы замещенного бензимидазола и способ их применения
SE9601368D0 (sv) Process for the production of a porous cross-linked polysaccharide gel
BRPI0410042A (pt) resina hidrófila e seu processo de produção
RU2015101105A (ru) Способ получения композиции на основе гиалуроновой кислоты
WO1998050082A3 (en) Tissue fixation with cross-linking compounds
CN113861447B (zh) 一种改性羟丙基壳聚糖粘附自愈水凝胶及其制备方法和应用
CN105343924A (zh) 一种使用多巴胺快速交联壳聚糖制备止血海绵的方法
DE50310078D1 (de) Verwendung von 2,6-di-tert.-butyl-p-kresol zur erh
NO20044308L (no) Aerogel basert pa en hydroksykarbonholding polymer eller kopolymer og fremgangsmate for fremstilling derav
CN103819685A (zh) 鱼鳞胶原蛋白接枝壳聚糖及其制备方法、用途
BRPI0707404A8 (pt) Método para a purificação de um polímero reabsorvível a partir de monômeros residuais
DK1638609T3 (da) Fremgangsmåde til fremstilling af molekylekomplekser
Bae et al. In situ formation of enzyme-free hydrogels via ferromagnetic microbead-assisted enzymatic cross-linking
MX2021003037A (es) Metodo para tratar una membrana microporosa.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1711552

Country of ref document: EP